T1	Claim 592 658	Increase the dose of inhaled corticosteroids to 800 micrograms/day
T2	Claim 663 677	Add tiotropium
T3	Claim 682 723	Maintain the same pharmacological regimen
T4	Claim 728 826	Switch to ocmbined therapy with low-dose inhaled corticosteroids and long-acting beta2-adrenergics
T5	Claim 831 847	Add leukotrienes
T6	Claim 867 893	Asthma treatment algorithm
T7	Claim 895 974	We rule out continuing with the same treatment since the patient is symptomatic
R1	Attack Ent1:T7 Ent2:T3	
T8	Treatment 592 658	Increase the dose of inhaled corticosteroids to 800 micrograms/day
T9	Treatment 663 677	Add tiotropium
T10	Treatment 682 723	Maintain the same pharmacological regimen
T11	Treatment 728 826	Switch to ocmbined therapy with low-dose inhaled corticosteroids and long-acting beta2-adrenergics
T12	Treatment 831 847	Add leukotrienes
R2	Support Ent1:T6 Ent2:T4	
T13	Premise 287 400	The patient reports that in the last 3 months he has had no exacerbations and that he uses salbutamol once a day.
T14	Premise 401 495	He only has dyspnea when climbing stairs and some nights he sleeps irregularly due to coughing
T15	Premise 62 285	A patient diagnosed with bronchial asthma who is being treated with low-dose inhaled steroids (200 micrograms of budesonide every 12 hours) and rescue medication (salbutamol on demand) comes for periodic clinical monitoring
T16	Disease 867 873	Asthma
T17	Marker 898 906	rule out
